1.300
+0,00%
2026-10-16
Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -57.0% | -24.0% | 1 / 3 | +156.7% | +3.55 pp | -2.90 pp | +2.2% | 0.16 | 20.77 | 55,2 | +156,7% | 0,3 | −57,0% | 20.77 | 27.85 | −25,4% |
| Pts | 0 | 0 | 4 | 12 | 12 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 1.300 (close price on 2026-10-16)EPS (TTM): 62,6
Financial charts
1.Revenue & growth
VND bn55,2Q2/26
1.Revenue & growth
VND bn55,2Q2/26
2.Profit & growth
VND bn0,32Q2/26
3.Profit mix (Penman)
VND bn1,25Q2/26
4.Margins & cost structure
%7.5%Q2/26
5.Returns & cash cycle
% · days-3.5%Q2/26
6.Earnings quality & cash
VND bn15,5Q2/26
7.Asset structure
VND bn168Q2/26
8.Funding & debt health
VND bn · times168Q2/26
9.Revenue backlog
VND bn8,27Q2/26
10.Valuation
times · %20,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %16Q2/26
Adjusted EPS growth, latest quarter
-57.0%
Average adjusted EPS growth, 3 quarters
-24.0%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26